Skip to main content
Premium Trial:

Request an Annual Quote

Takara Bio USA Holdings Completes Acquisition of Rubicon Genomics

NEW YORK (GenomeWeb) – Takara Bio USA Holdings said today that it has completed its $75 million acquisition of Rubicon Genomics.

In December, Takara Bio USA Holdings announced that it had signed an agreement to acquire Rubicon as part of an effort to help its parent company — Shiga, Japan-based Takara Bio Group — to expand its presence in next-generation sequencing library preparation and genetic analysis, low-input and single-cell pre-analytical sample preparation, and in new clinical markets such as in vitro fertilization.

Rubicon — which markets DNA library preparation products for arrays and Illumina NGS platforms under the ThruPlex, PicoPlex, and TransPlex brand names — is now a wholly owned subsidiary of Takara Bio USA Holdings. The impact of the acquisition is not expected to materially impact Takara Bio Group's 2017 financial results.

"We are pleased to announce the completion of this transaction and officially welcome Rubicon to the Takara Bio Group," Takara Bio USA President Carol Lou said in a statement. "We now have an expanded NGS and genetic analysis capabilities that strengthen our product portfolio and allow us to better serve the life science research market, as well as creating new opportunities for us to serve customers in IVF and other clinical markets."

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.